Cantor Fitzgerald Reiterates a Buy Rating on Healthcare Realty

By Carrie Williams

In a report released today, Joseph France from Cantor Fitzgerald reiterated a Buy rating on Healthcare Realty (NYSE: HR), with a price target of $35. The company’s shares opened today at $29.44.

France said:

“The early sale to GMRE of three rehab properties pushes $68 million of expected 2017 dispositions into 2016, and is good news in a market that has.”

According to, France is a 4-star analyst with an average return of 5.4% and a 52.3% success rate. France covers the Healthcare sector, focusing on stocks such as WellCare Health Plans, Envision Healthcare, and Acadia Healthcare.

Healthcare Realty has an analyst consensus of Moderate Buy, with a price target consensus of $35.

Based on Healthcare Realty’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $104 million and quarterly net profit of $11.83 million. In comparison, last year the company earned revenue of $96.73 million and had a net profit of $16.91 million.

Based on the recent corporate insider activity of 50 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of HR in relation to earlier this year. Earlier this month, David R. Emery, the Chairman of HR bought 72,000 shares for a total of $1,990,775.

Healthcare Realty Trust, Inc. is a publicly-traded Real Estate Investment Trust (REIT). It engages in owning, managing, acquiring, and developing outpatient medical facilities. The company was founded by David R. Emery in 1992 and is headquartered in Nashville, TN.